Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Regulatory information - EMA releases practical guidance on access-to-documents requests 24 november 2014NewsCorporate Regulatory update - EMA encourages companies to submit type-I variations for 2014 by end of November 21 november 2014NewsCorporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014 21 november 2014NewsHuman Cerdelga recommended for approval in type 1 Gaucher disease 21 november 2014Press releaseHuman Two new medicines recommended for the treatment of chronic hepatitis C 21 november 2014Press releaseHuman EMA recommends availability of ellaOne emergency contraceptive without prescription 21 november 2014Press releaseHuman European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine) 21 november 2014Press releaseHumanMedicines CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls 21 november 2014Press release No consistent evidence of an increased risk of heart problems with testosterone medicines 21 november 2014Press release Conflicts of interests: revised EMA policy reflects more balanced approach 20 november 2014Press releaseCorporate 1 … 184 185 186 187 188 Page 188 of 380 189 190 191 192 … 380
Regulatory information - EMA releases practical guidance on access-to-documents requests 24 november 2014NewsCorporate
Regulatory update - EMA encourages companies to submit type-I variations for 2014 by end of November 21 november 2014NewsCorporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014 21 november 2014NewsHuman
Two new medicines recommended for the treatment of chronic hepatitis C 21 november 2014Press releaseHuman
EMA recommends availability of ellaOne emergency contraceptive without prescription 21 november 2014Press releaseHuman
European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine) 21 november 2014Press releaseHumanMedicines
CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls 21 november 2014Press release
No consistent evidence of an increased risk of heart problems with testosterone medicines 21 november 2014Press release
Conflicts of interests: revised EMA policy reflects more balanced approach 20 november 2014Press releaseCorporate